4.6 Review

Subolesin/Akirin Vaccines for the Control of Arthropod Vectors and Vectorborne Pathogens

Journal

TRANSBOUNDARY AND EMERGING DISEASES
Volume 60, Issue -, Pages 172-178

Publisher

WILEY
DOI: 10.1111/tbed.12146

Keywords

akirin; subolesin; tick; mosquito; fly; mite; lice

Funding

  1. Walter R. Sitlington Endowed Chair for Food Animal Research
  2. JAE-DOC programme (CSIC-FSE), Spain
  3. POSTICK ITN (Postgraduate training network for capacity building to control ticks and tickborne diseases) within the FP7-PEOPLE - ITN programme (EU) [38511]
  4. [BFU2011-23896]
  5. [FAU2008-00014-00-00]
  6. [PEII09-0118-8907]

Ask authors/readers for more resources

Diseases transmitted by arthropod vectors such as mosquitoes, ticks and sand flies greatly impact human and animal health, and therefore, their control is important for the eradication of vectorborne diseases (VBD). Vaccination is an environmentally friendly alternative for vector control that allows control of several VBD by targeting their common vector. Recent results have suggested that subolesin (SUB) and its orthologue in insects, akirin (AKR) are good candidate antigens for the control of arthropod vector infestations and pathogen infection. SUB was discovered as a tick-protective antigen in Ixodes scapularis. Vaccination trials with recombinant SUB/AKR demonstrated effective control of arthropod vector infestations in various hard and soft tick species, mosquitoes, sand flies, poultry red mites and sea lice by reducing their numbers, weight, oviposition, fertility and/or moulting. SUB/AKR vaccination also reduced tick infection with tickborne pathogens, Anaplasma phagocytophilum, A.marginale, Babesia bigemina and Borrelia burgdorferi. The effect of vaccination on different hosts, vector species, developmental stages and vectorborne pathogen infections demonstrated the feasibility of SUB/AKR universal vaccines for the control of multiple vector infestations and for reduction in VBD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available